当前位置: 首页 > 期刊 > 《中国药房》 > 2025年第15期
编号:2440083
伊朗分枝杆菌感染的案例报道及文献分析4
http://www.100md.com 2025年9月2日 中国药房 2025年第15期
     中图分类号R915 文献标志码A 文章编号 1001-0408(2025)15-1931-05

    DOI10.6039/j.issn.1001-0408.2025.15.20

    Casereportand literatureanalysisofMycobacteriumiranicuminfection

    ZHANG Yewen1,2,LUO Chengling',JIANG Wengao’,CHEN Min,DU Qian4,YAO Wei3,LIU Songqing4,XI Xin4 (1.College of Pharmacy,Chongqing Medical University,Chongqing 401120,China;2.School of Basic Medicine and Clinical Pharmacy,China Pharmaceutical University,Nanjing 210oo0,China;3.Dept.of Respiratory Medicine,Third Afiliated Hospital of Chongqing Medical University,Chongqing 401120,China; 4.Dept.of Pharmacy,Third Afiliated Hospital of Chongqing Medical University,Chongqing 401120,China)

    ABSTRACTOBJECTIVEToofferareference forthe treatmentofMycobacteriumiranicum infectionbyanalyzingthediagnosis and managementofasinglecasealongside literature-reportedcases.METHODSThroughcasereportandliteraturereviews,this studysynthesizedtheclinicalfeatures,therapeuticregimens,andpatientoutcomesofthoseinfectedwithM.iranicum.RESULS Inthesinglecasedocumentedinthisreport,subsequenttolinicalpharmacists’involvementintheconsultation,thepatientwas prescribed a therapeutic regimen comprising levofloxacin( 0.5g ......

您现在查看是摘要页,全文长 15788 字符